OvaScience Company Profile (NASDAQ:OVAS)

About OvaScience (NASDAQ:OVAS)

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:OVAS
  • CUSIP: N/A
  • Web: www.ovascience.com
Capitalization:
  • Market Cap: $46 million
  • Outstanding Shares: 35,662,000
Average Prices:
  • 50 Day Moving Avg: $1.43
  • 200 Day Moving Avg: $1.94
  • 52 Week Range: $1.26 - $8.98
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.02
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $569,999.00
  • Price / Sales: 80.71
  • Book Value: $2.66 per share
  • Price / Book: 0.48
Profitability:
  • EBIDTA: ($64,780,000.00)
  • Net Margins: -11,642.67%
  • Return on Equity: -62.66%
  • Return on Assets: -57.12%
Debt:
  • Current Ratio: 11.85%
  • Quick Ratio: 11.85%
Misc:
  • Average Volume: 772,872 shs.
  • Beta: 3.73
  • Short Ratio: 5.15
 

Frequently Asked Questions for OvaScience (NASDAQ:OVAS)

What is OvaScience's stock symbol?

OvaScience trades on the NASDAQ under the ticker symbol "OVAS."

How were OvaScience's earnings last quarter?

OvaScience Inc (NASDAQ:OVAS) released its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.38) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.46) by $0.08. The firm had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.12 million. OvaScience had a negative return on equity of 62.66% and a negative net margin of 11,642.67%. The company's quarterly revenue was down 56.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.80) earnings per share. View OvaScience's Earnings History.

Where is OvaScience's stock going? Where will OvaScience's stock price be in 2017?

5 brokers have issued 1 year target prices for OvaScience's shares. Their predictions range from $1.00 to $15.00. On average, they expect OvaScience's stock price to reach $8.00 in the next year. View Analyst Ratings for OvaScience.

Who are some of OvaScience's key competitors?

Who are OvaScience's key executives?

OvaScience's management team includes the folowing people:

  • Michelle Dipp M.D., Ph.D., Executive Chairman of the Board, Acting President, Chief Executive Officer, Principal Executive Officer
  • Christophe Couturier, Chief Financial Officer
  • Karen Long, Executive Vice President - Clinical and Regulatory Affairs and Quality Assurance
  • James Luterman Ph.D., Executive Vice President - Research and Development
  • Theresa McNeely, Executive Vice President, Chief Communications Officer
  • Ravi Mehrotra Ph.D., Chief Corporate Development Officer
  • John P. Howe III M.D., Director
  • John E. Sexton Ph.D., Director
  • Jeffrey D. Capello, Independent Director
  • Mary M. Fisher, Independent Director

Who owns OvaScience stock?

OvaScience's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (14.99%), EcoR1 Capital LLC (9.85%), Jennison Associates LLC (6.13%), Vanguard Group Inc. (4.64%), GMT Capital Corp (2.12%) and Sabby Management LLC (1.19%). Company insiders that own OvaScience stock include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich. View Institutional Ownership Trends for OvaScience.

Who sold OvaScience stock? Who is selling OvaScience stock?

OvaScience's stock was sold by a variety of institutional investors in the last quarter, including Tudor Investment Corp ET AL, Wells Fargo & Company MN, Bank of New York Mellon Corp, TIAA CREF Investment Management LLC and Teachers Advisors LLC. View Insider Buying and Selling for OvaScience.

Who bought OvaScience stock? Who is buying OvaScience stock?

OvaScience's stock was bought by a variety of institutional investors in the last quarter, including EcoR1 Capital LLC, Sabby Management LLC, Vanguard Group Inc., GMT Capital Corp, KCG Holdings Inc., UBS Asset Management Americas Inc., Northern Capital Management LLC and Geode Capital Management LLC. Company insiders that have bought OvaScience stock in the last two years include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich. View Insider Buying and Selling for OvaScience.

How do I buy OvaScience stock?

Shares of OvaScience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OvaScience's stock price today?

One share of OvaScience stock can currently be purchased for approximately $1.29.


MarketBeat Community Rating for OvaScience (NASDAQ OVAS)
Community Ranking:  2.9 out of 5 ( )
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about OvaScience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $8.00 (520.16% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017HC WainwrightReiterated RatingBuy$15.00LowView Rating Details
4/18/2017Credit Suisse Group AGReiterated RatingUnderperform -> Underperform$1.00LowView Rating Details
3/22/2017Oppenheimer Holdings Inc.Reiterated RatingHoldMediumView Rating Details
8/10/2016JMP SecuritiesReiterated RatingNeutralN/AView Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetNeutral$9.00 -> $8.00N/AView Rating Details
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00N/AView Rating Details
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83N/AView Rating Details
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00N/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for OvaScience (NASDAQ:OVAS)
Earnings by Quarter for OvaScience (NASDAQ:OVAS)
Earnings History by Quarter for OvaScience (NASDAQ OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.46)($0.38)$0.12 million$0.06 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.58)($0.64)$0.11 million$0.12 millionViewListenView Earnings Details
11/3/2016Q316($0.62)($0.54)$0.25 million$0.02 millionViewListenView Earnings Details
8/4/2016Q216($0.78)($0.62)$0.21 million$0.19 millionViewListenView Earnings Details
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details
2/25/2016Q315($0.71)($0.76)$0.20 million$0.16 millionViewListenView Earnings Details
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details
8/10/2015Q215($0.64)($0.64)$0.57 million$0.03 millionViewN/AView Earnings Details
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OvaScience (NASDAQ:OVAS)
2017 EPS Consensus Estimate: ($1.41)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.35)($0.35)($0.35)
Q2 20171($0.37)($0.37)($0.37)
Q3 20171($0.36)($0.36)($0.36)
Q4 20171($0.33)($0.33)($0.33)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for OvaScience (NASDAQ:OVAS)
Insider Ownership Percentage: 12.59%
Institutional Ownership Percentage: 79.61%
Insider Trades by Quarter for OvaScience (NASDAQ:OVAS)
Institutional Ownership by Quarter for OvaScience (NASDAQ:OVAS)
Insider Trades by Quarter for OvaScience (NASDAQ:OVAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for OvaScience (NASDAQ:OVAS)
Latest Headlines for OvaScience (NASDAQ:OVAS)
Source:
DateHeadline
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 23 at 6:35 PM
americanbankingnews.com logoOvaScience Inc (OVAS) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 19 at 1:42 PM
americanbankingnews.com logoZacks Investment Research Lowers OvaScience Inc (OVAS) to Sell
www.americanbankingnews.com - May 13 at 7:52 AM
americanbankingnews.com logoOvaScience's (OVAS) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 12 at 5:20 PM
americanbankingnews.com logoQ2 2017 EPS Estimates for OvaScience Inc Cut by Oppenheimer Holdings (OVAS)
www.americanbankingnews.com - May 12 at 8:50 AM
seekingalpha.com logoOvaScience beats by $0.01, misses on revenue
seekingalpha.com - May 12 at 12:34 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Expected to Post Quarterly Sales of $130,000.00
www.americanbankingnews.com - May 11 at 12:20 PM
americanbankingnews.com logoOvaScience Inc (OVAS) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 10 at 7:40 PM
finance.yahoo.com logoEdited Transcript of OVAS earnings conference call or presentation 9-May-17 8:30pm GMT
finance.yahoo.com - May 10 at 11:47 AM
finance.yahoo.com logoOvaScience Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 9 at 6:41 PM
finance.yahoo.com logoOvaScience reports 1Q loss
finance.yahoo.com - May 9 at 6:41 PM
americanbankingnews.com logo-$0.46 Earnings Per Share Expected for OvaScience Inc (OVAS) This Quarter
www.americanbankingnews.com - May 9 at 7:46 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - May 7 at 6:26 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 5 at 7:22 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) and Lead Plaintiff Deadline - May 29, 2017
finance.yahoo.com - May 4 at 7:16 PM
americanbankingnews.com logoSomewhat Favorable Media Coverage Extremely Likely to Impact OvaScience (OVAS) Share Price
www.americanbankingnews.com - May 4 at 2:34 PM
businesswire.com logoOvaScience to Host First Quarter 2017 Financial Results Conference Call
www.businesswire.com - May 3 at 7:57 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those with Losses in Excess of $100,000 from Investment in OvaScience, Inc. to Contact the Firm
finance.yahoo.com - May 2 at 4:52 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - May 2 at 4:52 PM
americanbankingnews.com logoOvaScience (OVAS) Receives Daily Media Impact Score of 0.26
www.americanbankingnews.com - May 1 at 3:32 PM
americanbankingnews.com logoOvaScience (OVAS) Earns News Impact Score of 0.17
www.americanbankingnews.com - April 28 at 4:45 PM
americanbankingnews.com logoOvaScience Inc (OVAS) Short Interest Up 29.7% in April
www.americanbankingnews.com - April 27 at 7:16 AM
americanbankingnews.com logoOvaScience (OVAS) Getting Somewhat Positive Media Coverage, Analysis Shows
www.americanbankingnews.com - April 25 at 6:46 PM
prnewswire.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To ... - PR Newswire (press release)
www.prnewswire.com - April 21 at 9:05 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Expected to Post Quarterly Sales of $120,000.00
www.americanbankingnews.com - April 20 at 1:53 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit Against OvaScience, Inc.
finance.yahoo.com - April 19 at 7:07 PM
americanbankingnews.com logoCredit Suisse Group AG Begins Coverage on OvaScience Inc (OVAS)
www.americanbankingnews.com - April 18 at 11:50 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Expected to Announce Earnings of -$0.46 Per Share
www.americanbankingnews.com - April 18 at 11:38 AM
americanbankingnews.com logoOvaScience (OVAS) Earns Coverage Optimism Score of 0.16
www.americanbankingnews.com - April 17 at 11:03 PM
americanbankingnews.com logoOvaScience (OVAS) Earning Positive Media Coverage, Report Finds
www.americanbankingnews.com - April 13 at 5:27 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - April 11 at 10:40 AM
finance.yahoo.com logoRobbins Arroyo LLP: OvaScience, Inc. (OVAS) Misled Shareholders According to a Recently Filed Class Action
finance.yahoo.com - April 10 at 6:36 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against OvaScience, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - April 7 at 11:45 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Short Interest Up 9.1% in March
www.americanbankingnews.com - April 6 at 1:28 PM
americanbankingnews.com logoOvaScience Inc (OVAS) Receives $5.50 Consensus Target Price from Analysts
www.americanbankingnews.com - April 4 at 9:17 AM
reuters.com logoBRIEF-Ecor1 Capital Llc reports a 9.9 pct passive stake in Ovascience as of march 23 - SEC Filing
www.reuters.com - March 31 at 7:12 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline - May 29, 2017
finance.yahoo.com - March 31 at 7:12 PM
finance.yahoo.com logoEdited Transcript of OVAS earnings conference call or presentation 2-Mar-17 9:30pm GMT
finance.yahoo.com - March 31 at 7:12 PM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against OvaScience, Inc.
finance.yahoo.com - March 31 at 7:12 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against OvaScience, Inc. and Encourages Investors With Losses to Contact the Firm
finance.yahoo.com - March 31 at 12:25 AM
finance.yahoo.com logoIMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchase
finance.yahoo.com - March 30 at 7:21 PM
prnewswire.com logoLifshitz & Miller LLP Files Class Action Lawsuit against OvaScience, Inc. - PR Newswire (press release)
www.prnewswire.com - March 30 at 12:53 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In OvaScience, Inc. (OVAS) To Contact Brower Piven Before The Lead Plaintiff Deadline
finance.yahoo.com - March 29 at 7:50 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To Contact The Firm
finance.yahoo.com - March 28 at 6:53 PM
americanbankingnews.com logoOvaScience Inc (OVAS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 28 at 1:46 PM
finance.yahoo.com logoLifshitz & Miller LLP Files Class Action Lawsuit against OvaScience, Inc.
finance.yahoo.com - March 28 at 9:53 AM
americanbankingnews.com logoOvaScience's (OVAS) Hold Rating Reaffirmed at Oppenheimer Holdings Inc.
www.americanbankingnews.com - March 28 at 7:11 AM
nasdaq.com logoOvaScience (OVAS) Shares March Higher, Can It Continue? - Nasdaq
www.nasdaq.com - March 26 at 8:14 AM
americanbankingnews.com logoOvaScience Inc (OVAS) Receives "Hold" Rating from Oppenheimer Holdings Inc.
www.americanbankingnews.com - March 25 at 12:58 AM
finance.yahoo.com logoOvaScience (OVAS) Shares March Higher, Can It Continue?
finance.yahoo.com - March 24 at 8:33 AM

Social

Chart

OvaScience (OVAS) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff